| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/08/2008 | DE202005021489U1 Zusammmensetzung für die Synthese von phosphitylierten Verbindungen A composition as for the synthesis of compounds phosphitylated |
| 05/08/2008 | DE202005021488U1 Mischung aus einem Aktivator und einem Additiv zur Herstellung von phosphitylierten Verbindungen Mixture of an activator and an additive for preparing phosphitylated compounds |
| 05/07/2008 | EP1918282A1 Method for preparing medetomidine and its salts |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917251A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917250A2 Anti-inflammatory aryl nitrile compounds |
| 05/07/2008 | EP1608627B1 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/06/2008 | US7368579 E.g., 2-bromo- or 2-chloro-1-(2-methyl-2-oxiranylmethyl)-4-nitroimidazole; intermediates for antitubercular agents |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | US7368467 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/06/2008 | CA2125636C Process for preparing an .alpha.-amino acid amide, useful for peptidic synthesis |
| 05/02/2008 | WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008049595A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/02/2008 | WO2008019030A8 Modified azole compounds as antiinfective agents |
| 05/02/2008 | CA2667507A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/01/2008 | US20080103307 chroman compound, the method of its preparation and pharmaceutical applications. The compound are represented by formula (I) and its pharmaceutical salt, where in :x is for O or S; n is for 2, 3 or 4; R1 is 6-situ or 7-situ halogen, C1-4alkyl, C1-4alkyoxyl, benzyloxy, acylamino; R2 is nitrogen-containin |
| 05/01/2008 | US20080103183 New imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 05/01/2008 | US20080102405 Nitrogen-containing organic compound, resist composition and patterning process |
| 05/01/2008 | US20080102026 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 04/30/2008 | EP1506168B1 Gelling agents |
| 04/30/2008 | CN101171109A Method to impregnate lignocellulosic material with effect agent |
| 04/30/2008 | CN100384837C Novel farnesyl protein transferase inhibitors as antitumor |
| 04/29/2008 | US7365210 Method for the production of chiral imidazolidin-2-ones |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365075 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
| 04/29/2008 | US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008049027A1 Talarazole metabolites |
| 04/24/2008 | WO2008047388A2 Improved process for the preparation of ranolazine |
| 04/24/2008 | WO2008046757A1 Aminomethyl-4-imidazoles |
| 04/24/2008 | WO2008046756A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/24/2008 | US20080097107 1-substituted-4-nitroimidazole compound and method for preparing the same |
| 04/24/2008 | US20080097103 Imidazole-2-thiones |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080097061 Oxylamino Group-Containing Compound and Polymer |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096918 2-(3-(4-benzyloxybenzyl)-2-oxoimidazolidin-1-yl)-N-hydroxy-3-methylbutyramide; N-hydroxy-3-methyl-2-{2-oxo-3-(4-(pyridin-4-ylmethoxy)benzyl)imidazolidin-1-yl}butyramide with trifluoroacetic acid ; osteoarthrosis and rheumatoid arthritis; TNF- alpha converting enzyme (TACE) inhibitor |
| 04/24/2008 | US20080096906 good affinity to the trace amine associated receptors (TAARs), especially for TAAR1; (3-Chloro-phenyl)-(1H-imidazol-2-ylmethyl)-methyl-amine from 3-chloro-N-methylaniline and imidazole-2-carboxyaldehyde and reduction of the carbonyl to methylene |
| 04/24/2008 | US20080096888 Novel compounds as opioid receptor modulators |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis |
| 04/24/2008 | US20080096240 Novel prostamide receptor antagonists |
| 04/24/2008 | US20080092307 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride |
| 04/24/2008 | CA2667053A1 Talarazole metabolites |
| 04/24/2008 | CA2666762A1 Aminomethyl-4-imidazoles |
| 04/24/2008 | CA2665255A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1912972A1 Substituted imidazole compounds as ksp inhibitors |
| 04/23/2008 | EP1912679A2 Amine-containing lipids and uses thereof |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | CN101166797A Method and use of nanoparticles to bind biocides in paints |
| 04/23/2008 | CN101165048A Method for preparing polyisocyanic acid ester |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/22/2008 | US7361769 Metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 04/22/2008 | US7361761 Process for the preparation of bisphosphonic acid |
| 04/22/2008 | US7361755 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2008043309A1 Process and system of preparing ultra pure ionic liquids |
| 04/17/2008 | WO2008017932A3 Heterocycles useful as inhibitors of carbonic anhydrase |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | WO2007143745A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080091028 selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; pain |
| 04/17/2008 | US20080091027 React azole derivative in hydrocarbon, ether solvent at mild temperaturein the presence of a catalytic iridium boron cyclooctadiene complex; intermediates to natural and synthetic functionalized compounds; cytotoxic, anticancer and antiviral agents |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090888 Methods and materials for assessing prostate cancer therapies and compounds |
| 04/17/2008 | US20080090855 Substituted Cyclic Urea Derivatives and the Use Thereof as Vanilloid Receptor 1 Modulators |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | DE102006048042A1 Acylaminoimidazole und Acylaminothiazole Acylaminoimidazole and Acylaminothiazole |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/16/2008 | EP1911829A1 Process for deacidifying crude oil |
| 04/16/2008 | EP1911757A2 Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910310A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 04/16/2008 | EP1910309A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION |
| 04/16/2008 | EP1910308A1 Imidazole based lxr modulators |
| 04/16/2008 | EP1910307A1 Pyrazole based lxr modulators |
| 04/16/2008 | EP1910306A1 Carbon-nitrogen bond forming process |
| 04/16/2008 | EP1910305A1 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| 04/16/2008 | EP1910304A2 Therapeutic agents |
| 04/16/2008 | EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 04/16/2008 | EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
| 04/16/2008 | CN101163680A Preparation of 2-substituted 4-chloro-5-formylimidazoles by vilsmeier reaction of the condensation product of glycine and an imido ester with a formamide in the presence of a triflate (trifluormethane |